Janssen vaccine reports efficacy after single injection: FDA decision imminent
24 February 2021. Related: COVID-19: vaccine research, COVID-19.
COVID-19
Oxford/AZ vaccine might still prevent severe COVID-19 from B.1.351 variant: supports continued used in South Africa
24 February 2021. Related: COVID-19: vaccine research, COVID-19.
Unprecedented rapid speed of COVID vaccine development
24 February 2021. Related: COVID-19: vaccine research, COVID-19.
WHO online vaccine tracker
24 February 2021. Related: COVID-19: vaccine research, COVID-19.
COVID-19 vaccine pricing: a BBC guide
24 February 2021. Related: COVID-19: vaccine research, COVID-19: treatment access, COVID-19.
Tocilizimab effectively reduces COVID-19 related deaths and hospitalisation time: additive benefit with dexamethasone
24 February 2021. Related: COVID-19: investigational drugs, COVID-19.
Bamlanivimab (LY-CoV555) prophylaxis prevents COVID-19 in care homes: results of BLAZE-2 study
24 February 2021. Related: COVID-19: investigational drugs, COVID-19.
US FDA specifies high antibody titre for convalescent plasma and to only use in early COVID-19
24 February 2021. Related: COVID-19: investigational drugs, COVID-19.
No benefit from convalescent plasma in UK RECOVERY study: limited results restrict implications for COVID-19
24 February 2021. Related: COVID-19: investigational drugs, COVID-19.
UK variant B.1.1.7 linked to higher risk of death and hospitalisation from COVID-19
24 February 2021. Related: COVID-19: pathogenesis, COVID-19.
NICE issue UK guidelines on long COVID
22 January 2021. Related: COVID-19: guidelines, COVID-19.
BHIVA and EACS update HIV as a higher risk for COVID-19: supports priority vaccine (January 2021)
22 January 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Recent studies on HIV and COVID-19 coinfection
22 January 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Very low-level HIV viraemia might continue after COVID-19
22 January 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: pathogenesis, COVID-19.
Pfizer COVID-19 vaccine might still overcome UK and SA variants
22 January 2021. Related: COVID-19: vaccine research, COVID-19.
Novavax phase 3 vaccine study launched in the UK, South Africa, US, Mexico and Puerto Rico
22 January 2021. Related: COVID-19: vaccine research, COVID-19.
Merck/MSD withdraws two vaccine candidates from further research but continues focus on treatment
22 January 2021. Related: COVID-19: vaccine research, COVID-19: investigational drugs, COVID-19.
Oral colchicine reduces hospitalisation in international randomised phase 3 outpatient study
22 January 2021. Related: COVID-19: investigational drugs, COVID-19.
IL-6 agonists tocilizumab and sarilumab reduces mortality in severe COVID-19: interim results from REMAP-CAP study
22 January 2021. Related: COVID-19: investigational drugs, COVID-19.
Two different dual antibody treatments each reduce SARS-CoV-2 viral load by >0.5 log
22 January 2021. Related: COVID-19: investigational drugs, COVID-19.
IV methylprednisolone pulse treatment for hospitalised severe COVID-19
22 January 2021. Related: COVID-19: investigational drugs, COVID-19.
Monoclonal antibody bamlanivimab is not effective in advanced COVID-19: lack of early signal stops study early
22 January 2021. Related: COVID-19: investigational drugs, COVID-19.
Azithromycin monotherapy shows no benefit for COVID-19: RECOVERY study reports 1493 further deaths
22 January 2021. Related: COVID-19: investigational drugs, COVID-19: research studies, COVID-19.
WHO strongly recommended against using hydroxychloroquine or lopinavir/r at any stage of COVID-19
22 January 2021. Related: COVID-19: guidelines, COVID-19.
Updated US guidelines for treating COVID-19 (December 2020)
22 January 2021. Related: COVID-19: guidelines, COVID-19.
US update guidelines on access to COVID vaccines
22 January 2021. Related: COVID-19: guidelines, COVID-19.
Webcasts of two-day US Workshop on Long COVID (PASC) now online
22 January 2021. Related: COVID-19: long COVID, COVID-19: pathogenesis, COVID-19: on the web, COVID-19.
Most people hospitialised with COVID-19 have at least one symptom after 6 months: Wuhan cohort
22 January 2021. Related: COVID-19: pathogenesis, COVID-19.
Recent studies on HIV and COVID-19 coinfection
9 December 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Early safety and immune responses in older people using the Oxford vaccine: overall results complicated by dosing error
9 December 2020. Related: COVID-19: vaccine research, COVID-19.
Interim results report 94% efficacy with Moderna/NIH mRNA vaccine: FDA hearing on 17 December
9 December 2020. Related: COVID-19: vaccine research, COVID-19.
HIV risk from some COVID-19 vaccines might be unlikely due to rarity of vector viruses involved
9 December 2020. Related: COVID-19: vaccine research, COVID-19.
JAK inhibitor baricitinib in moderate/severe COVID-19
9 December 2020. Related: COVID-19: investigational drugs, COVID-19.
Hydroxychloroquine fails to prevent COVID-19 or SARS-CoV-2 transmission when used as PEP
9 December 2020. Related: COVID-19: investigational drugs, COVID-19: transmission & prevention, COVID-19.
Hydroxychloroquine has no benefit on symptoms at 14 days
9 December 2020. Related: COVID-19: investigational drugs, COVID-19.
WHO SOLIDARITY study published in NEJM
9 December 2020. Related: COVID-19: investigational drugs, COVID-19.
International COVID-19 study launches in Africa but with drugs that have little chance of working (ANTICOV)
9 December 2020. Related: COVID-19: investigational drugs, COVID-19: research studies, COVID-19.
Serious complications commonly reported three months after recovery from COVID-19
9 December 2020. Related: COVID-19: complications, COVID-19: pathogenesis, COVID-19.
Adverse pregnancy outcomes among Spanish women hospitalised with COVID-19
11 November 2020. Related: Conference reports, Pregnancy, COVID-19: transmission & prevention, COVID-19.
COVID-19 antibody testing for HIV positive people in the UK: HIV organisations reverse previous exclusion
11 November 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: diagnostics, COVID-19.
HIV positive people at higher risk of worse outcomes from COVID-19 in UK study
11 November 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Remdesivir given full approval by the US FDA, but on limited data
11 November 2020. Related: COVID-19: investigational drugs, COVID-19.
DSMB stops REGN-COV2 (casirivimab/imdevimab) monoclonal antibody study in people with high-flow oxygen or ventilation: implications for UK RECOVERY study
11 November 2020. Related: COVID-19: investigational drugs, COVID-19.
Monoclonal antibody stopped in ACTIV-3 study: bamlanivimab shows lack of benefit in people hospitalised with COVID-19
11 November 2020. Related: COVID-19: investigational drugs, COVID-19.
Early results report 90% efficacy with from Pfizer/BioNTech COVID vaccine
11 November 2020. Related: Special reports, COVID-19: vaccine research, COVID-19.
Convalescent plasma: randomised controlled study finds no benefit in moderate stage COVID-19
11 November 2020. Related: COVID-19: investigational drugs, COVID-19.
No survival benefit from remdesivir, hydroxychloroquine, lopinavir/r or interferon-β1a in moderate and severe COVID-19: interim results from the WHO SOLIDARITY study
11 November 2020. Related: COVID-19: investigational drugs, COVID-19.
COVID-19: pathogenesis and treatment
14 October 2020. Related: Conference reports, COVID-19: investigational drugs, COVID-19.
US study of HIV positive people with COVID-19 reports worse outcomes with comorbidities and having a CD4 <200
14 October 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Outcomes from COVID-19 in French cohort of 54 HIV positive people on ART
14 October 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Tocilizumab fails to meet clinical endpoints in randomised COVACTA study: other studies continue
14 October 2020. Related: COVID-19: investigational drugs, COVID-19.
COVID-19 reinfection can occur after varying times and with more severe disease
14 October 2020. Related: COVID-19: transmission & prevention, COVID-19.
Transmission from children to family members in US childcare setting
14 October 2020. Related: COVID-19: transmission & prevention, COVID-19.
BHIVA update guidance for HIV care during second wave of COVID-19
14 October 2020. Related: COVID-19: guidelines, COVID-19.
COVID-19 deaths in children and people <21 years old in the US
14 October 2020. Related: COVID-19: paediatrics, COVID-19.
IDSA guidelines on serologic testing for SARS-CoV-2
14 October 2020. Related: COVID-19: diagnostics, COVID-19.
Long COVID: Mild infection and sustained long-term complications
14 October 2020. Related: COVID-19: pathogenesis, COVID-19.
Review paper highlights substandard COVID-19 research in both peer-review journals and pre-review websites
14 October 2020. Related: COVID-19: other news, COVID-19.
Oxford COVID vaccine enrolling HIV positive people at two London sites
11 October 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19.
COVID-19 outcomes in HIV positive people in two large US cohorts
28 August 2020. Related: Conference reports, COVID-19: HIV and COVID-19 coinfection, COVID-19.
HIV associated with worse outcomes from COVID-19 in UK ISARIC and OpenSAFELY databases
28 August 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
European and UK doctors review latest studies on HIV and COVID-19 coinfection
28 August 2020. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
Tocilizumab associated with better outcomes from COVID-19 in US study
28 August 2020. Related: COVID-19: investigational drugs, COVID-19.
Famotidine associated with better outcomes from COVID-19
28 August 2020. Related: COVID-19: investigational drugs, COVID-19.
INSIGHT network to study monoclonal antibodies for COVID-19 including LY-CoV555
28 August 2020. Related: COVID-19: investigational drugs, COVID-19.